These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17566146)

  • 1. Low concentrations of resveratrol potentiate the antiplatelet effect of prostaglandins.
    Wu CC; Wu CI; Wang WY; Wu YC
    Planta Med; 2007 May; 73(5):439-43. PubMed ID: 17566146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP.
    Shen MY; Hsiao G; Liu CL; Fong TH; Lin KH; Chou DS; Sheu JR
    Br J Haematol; 2007 Nov; 139(3):475-85. PubMed ID: 17868048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet activity of synthetic and natural resveratrol in red wine.
    Bertelli AA; Giovannini L; Giannessi D; Migliori M; Bernini W; Fregoni M; Bertelli A
    Int J Tissue React; 1995; 17(1):1-3. PubMed ID: 7499059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT; Yen ML; Lin CY; Kuo ML
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of resveratrol on platelet aggregation in vivo and in vitro.
    Wang Z; Zou J; Huang Y; Cao K; Xu Y; Wu JM
    Chin Med J (Engl); 2002 Mar; 115(3):378-80. PubMed ID: 11940369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of COX-1 by red wine m-hydroquinones: a structure-activity relationship study.
    Szewczuk LM; Penning TM
    J Nat Prod; 2004 Nov; 67(11):1777-82. PubMed ID: 15568761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity.
    Yang YM; Chen JZ; Wang XX; Wang SJ; Hu H; Wang HQ
    Eur J Pharmacol; 2008 Mar; 583(1):148-55. PubMed ID: 18291361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin.
    Mardla V; Kobzar G; Samel N
    Platelets; 2004 Aug; 15(5):319-24. PubMed ID: 15370103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular protective effects of resveratrol.
    Bradamante S; Barenghi L; Villa A
    Cardiovasc Drug Rev; 2004; 22(3):169-88. PubMed ID: 15492766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase.
    Chang CC; Lu WJ; Chiang CW; Jayakumar T; Ong ET; Hsiao G; Fong TH; Chou DS; Sheu JR
    J Nutr Biochem; 2010 Dec; 21(12):1214-21. PubMed ID: 20015631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
    Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
    Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
    Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
    Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro.
    Wang Z; Huang Y; Zou J; Cao K; Xu Y; Wu JM
    Int J Mol Med; 2002 Jan; 9(1):77-9. PubMed ID: 11745001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide-mediated antiplatelet activity: pivotal role of the phospholipase C gamma 2-protein kinase C-p38 MAPK cascade.
    Lin KH; Chang YF; Fan CY; Jayakumar T; Lee JJ; Chou DS; Hsiao G; Sheu JR
    Transl Res; 2010 Feb; 155(2):97-108. PubMed ID: 20129490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
    Sheu JR; Hsiao G; Chou PH; Shen MY; Chou DS
    J Agric Food Chem; 2004 Jul; 52(14):4414-8. PubMed ID: 15237945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resveratrol-induced platelet apoptosis.
    Lin KH; Hsiao G; Shih CM; Chou DS; Sheu JR
    Cardiovasc Res; 2009 Aug; 83(3):575-85. PubMed ID: 19423619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Naphthoflavone, a potent antiplatelet flavonoid, is mediated through inhibition of phospholipase C activity and stimulation of cyclic GMP formation.
    Hsiao G; Chang CY; Shen MY; Chou DS; Tzeng SH; Chen TF; Sheu JR
    J Agric Food Chem; 2005 Jun; 53(13):5179-86. PubMed ID: 15969494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.